PGEN Competitors & Alternatives
Compare Precigen Inc with similar stocks in the same industry
Biotechnology
PGEN
Main Stock$4.31
Tradestie Score
63
Market Cap
$1.18B
Revenue Growth
2.8%
Analyst Upside
+120.4%
Top Competitors
230 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
VCEL
Vericel Corporation
|
$34.74
|
$1.56B | 77.0 | 58 | Compare |
|
DNTH
Dianthus Therapeutics, Inc. Common Stock
|
$82.98
|
$1.55B | - | 58 | Compare |
|
HRMY
Harmony Biosciences Holdings, Inc. Common Stock
|
$30.24
|
$1.55B | 12.4 | 60 | Compare |
|
PHVS
Pharvaris N.V. Ordinary Shares
|
$29.77
|
$1.55B | - | 61 | Compare |
|
NVAX
Novavax Inc
|
$9.18
|
$1.54B | - | 58 | Compare |
|
AUPH
Aurinia Pharmaceuticals Inc
|
$15.55
|
$1.50B | 7.1 | 59 | Compare |
|
GPCR
Structure Therapeutics Inc. American Depositary Shares
|
$37.37
|
$1.50B | - | 56 | Compare |
|
AMLX
Amylyx Pharmaceuticals, Inc. Common Stock
|
$13.11
|
$1.49B | - | 46 | Compare |
|
RCUS
Arcus Biosciences, Inc.
|
$24.38
|
$1.43B | - | 51 | Compare |
|
JANX
Janux Therapeutics, Inc. Common Stock
|
$13.76
|
$1.42B | - | 58 | Compare |
More PGEN Analysis
Data updated: May 18, 2026 | Industry: Biotechnology (SIC 2834)
230 stocks in this industry